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Case Presentation 
From May to September 2001, two women
and three men working in an industrial waste
treatment plant in Ulsan, Korea, developed
acute hepatitis. 
To more efﬁciently treat a larger quantity
of waste, in May 2000 the plant introduced a
new process solidifying liquid wastes through
thermochemical reaction evoked by unslaked
lime, thereby evaporating volatiles. During this
process, workers put 100–250 drums (200 L)
of liquid wastes and 7–12 tons of unslaked
lime into a vat of 10 m × 25 m × 1 m. The
thermochemical reaction started within
20 min, after which the workers stirred the
mixture a few times with an excavator
(Figure 1).
The reaction continued for at least 12 hr,
becoming more explosive over time; it gener-
ated high temperature and intermittent ﬁring,
and profusely spread malodorous vapors. The
warehouse had wide entrances on both sides,
and all the window glass on the external wall
had been removed, allowing the volatiles to
spread throughout the factory (Figure 1).
From May until November 2001, this process
was carried out > 10 times each month. On
18 September 2001, we sampled the waste oils
and solvents from the unslaked lime process
and analyzed them by gas chromatography-
mass selective detector (HP 5973 Series,
Hewlett Packard, Wellesley, MA, USA).
Because the process had been discontinued
after the hepatitis outbreaks, we simulated this
process on a smaller scale in the same building
where this process had been conducted. Several
chemicals, including dimethylformamide
(DMF), dimethylacetamide (DMAc), and
pyridine, were detected in some of the samples
collected from a walk-through before and after
the simulated process (Table 1).
Clinical course of the cases. Case 1, a
51-year-old male, had been employed in the
plant since 1986 and moved to the unslaked
lime process with two other co-workers in
July 2000. In April 2001, he had a single
episode of chest pain. In early May, while he
was hospitalized for the operation of sudden
onset retinal detachment, his liver function
was abnormal [aspartate aminotransferase
(AST), 317 IU/L; alanine aminotransferase
(ALT), 156 IU/L; alkaline phosphatase
(ALP), 225 IU/L; total bilirubin, 2.2 mg/dL].
Ten days later his liver function was
improved. He returned to work in the separa-
tor process in September, and then moved to
the dry evaporative incinerator in October.
However, his liver function worsened in
November and peaked in December (AST,
482 IU/L; ALT, 507 IU/L). After stopping
work, his liver function normalized. 
Case 2 was a male, 35 years of age, who
had started work in the evaporative concentra-
tion process in April 1994 with case 1. In late
June 2001, he felt severely fatigued and began
taking herbal medication 1 July to relieve
the fatigue. However, his fatigue did not
improve, and he developed insomnia, sweat-
ing, and jaundice 10 July. Case 2 was admit-
ted to the hospital on 12 July after developing
ascites with abnormal results of liver function
(AST, 1,982 IU/L; ALT, 1,226 IU/L; ALP,
420 IU/L). He was discharged after remission
of liver function on 30 August. After returning
to work, he had a car accident and received
injections of muscle relaxants and nonsteroidal
anti-inﬂammatory drugs (NSAIDs) once a day
for 8 days. He returned to work again on
24 September, but jaundice developed again
on 1 October. On admission to the hospital at
that time, his liver function worsened (AST,
737 IU/L; ALT, 432 IU/L; ALP, 541 IU/L;
total bilirubin, 13.7 mg/dL). His condition
worsened after admission, with severely
increased liver enzymes and jaundice (AST,
193 IU/L; ALT, 159 IU/L; total bilirubin,
37.6 mg/dL). He died on 14 October 2001. 
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CONTEXT: Industrial waste (which is composed of various toxic chemicals), changes to the disposal
process, and addition of chemicals should all be monitored and controlled carefully in the industrial
waste industry to reduce the health hazard to workers. 
CASE PRESENTATION: Five workers in an industrial waste plant developed acute toxic hepatitis, one of
whom died after 3 months due to fulminant hepatitis. In the plant, we detected several chemicals
with hepatotoxic potential, including pyridine, dimethylformamide, dimethylacetamide, and
methylenedianiline. The workers had been working in the high-vapor-generating area of the plant,
and the ﬁndings of pathologic examination showed typical features of acute toxic hepatitis. 
DISCUSSION: Infectious hepatitis and drug-induced hepatitis were excluded by laboratory ﬁndings, as
well as the clinical course of hepatitis. All cases of toxic hepatitis in this plant developed after the
change of the disposal process to thermochemical reaction–type treatment using unslaked lime reacted
with industrial wastes. During this chemical reaction, vapor containing several toxic materials was
generated. Although we could not conﬁrm the deﬁnitive causative chemical, we suspect that these
cases of hepatitis were caused by one of the hepatotoxic agents or by a synergistic interaction among
several of them.
RELEVANCE TO CLINICAL OR PROFESSIONAL PRACTICE: In the industrial waste treatment process, the
danger of developing toxic hepatitis should be kept in mind, because any subtle change of the treat-
ment process can generate various toxic materials and threaten the workers’ health. A mixture of
hepatotoxic chemicals can induce clinical manifestations that are quite different from those predicted
by the toxic property of a single agent.
KEY WORDS: complex exposure, dimethylacetamide, hepatotoxicity, industrial waste, liver biopsy,
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Research | Environmental MedicineCase 3, a 41-year-old female, had been a
repair and maintenance worker since 1993. In
early July 2001, she felt severe fatigue and
took two packs of herbal medicine given to
her by case 2. On 14 July, her liver function
test was normal. However, 1 week later her
urine darkened and jaundice developed in her
eyes. She was admitted to the hospital on
30 July with markedly increased liver enzymes
(AST, 1,670 IU/L; ALT, 1,223 IU/L; ALP,
495 IU/L). Her condition improved steadily,
and she was discharged on 19 September
2001. After returning to her job for 3 days,
she felt so fatigued that she did not return to
the workplace afterward. 
Case 4 was a female, 53 years of age. She
had been working in the sorting process since
September 2000. She developed jaundice early
in August 2001 and was admitted to the hospi-
tal on 24 August suffering from severe nausea.
Her liver enzymes were markedly elevated
(AST, 2,315 IU/L; ALT, 1,754 IU/L), biliru-
bin was elevated, and jaundice and mild ascites
developed. After being moved to a university
hospital, her condition improved gradually and
liver function normalized on 12 December.
Case 5, a 26-year-old male, was employed
in February 2001 and had been working in the
dry evaporative incineration process. He was
admitted to the hospital on 20 October 2001
due to jaundice and severely abnormal liver
function results (AST, 1,336 IU/L; ALT,
1,368 IU/L; ALP, 198 IU/L). His condition
improved, and he was discharged 8 November.
Table 2 summarizes the employment and
exposure history and clinical characteristics of
cases 1–5. Figure 2 presents the clinical course
of the cases as shown by AST concentration.
Liver biopsy was performed on all but one
case (case 2) in December 2001 (Figure 3).
The pathologic ﬁndings showed diffuse spotty
hepatocytic necrosis. The portal tracts were
slightly enlarged, and inﬂammatory inﬁltration
was present in all cases. Clumped Kupffer cells
containing periodic acid-Schiff (PAS)-positive
material were abundant, especially around the
terminal hepatic venule (Figure 3A). These
findings were compatible with the remission
stage of acute hepatitis and also with toxic
hepatitis. Wide periportal necrosis was also
identified in cases 1 and 4 (Figure 3D), and
necrosis was found in the central-to-portal or
portal-to-portal region, with bridging necrosis
in all cases (Figure 3C). In case 4, regenerative
nodules were present, suggesting the develop-
ment of cirrhosis. Cholestasis and fatty changes
were also evident in cases 4 and 3, respectively.
Markers for hepatitis A (anti-HAV IgM)
and B (HBsAg, HBeAg, anti-HBs, anti-HBc
IgM) were negative in all cases. Anti-hepatitis C
(anti-HCV) was positive in one case (case 1),
but HCV was not detected on polymerase
chain reaction (PCR). 
This study was approved by the institu-
tional review board of Dongguk University,
Gyeongju Hospital. Written informed consent
was received from all of the cases.
Discussion 
Clinical evaluation. Seven episodes of hepatitis
occurred in the ﬁve cases. Two of the patients
suffered double episodes, the second of which
occurred after the patient returned to work and
received possible reexposure to the hepatotoxic
agent(s). All of the episodes, except two, were
very similar in their clinical course, with the
duration of illness between 4 and 15 weeks
(median, 7 weeks). The disease onset was
highly concentrated within a narrow time
period between May and August 2001. 
The laboratory ﬁndings were quite similar
for all of the episodes. The ratio of the relative
increase of the measured values over the upper
normal limit of ALT (40 IU/L) to that of ALP
(120 IU/L) was > 5 in all cases, indicating that
the hepatic injury was primarily hepatocellular
rather than cholestatic. The hepatic lesions
with bridging necrosis were also compatible
with laboratory findings and clinical course.
These characteristic values correspond with
acute hepatocellular injury according to inter-
national criteria for diagnosis and classiﬁcation
(Danan and Benichou 1993). 
None of the cases had hematologic, renal,
or central nervous system symptoms or signs,
but all of them had respiratory discomfort and
dyspnea on exertion. None of the cases was
positive for the immunologic indices such as
antinuclear antibody or anti-smooth muscle
antibody, and none had fever. Their clinical
courses were acute hepatitis of less than
3-month duration. 
Two episodes were exceptional. The ﬁrst
episode for case 1 was asymptomatic, and the
liver enzyme level was not as elevated as the
other ﬁve episodes. Also, the R value [(maxi-
mum ALT/upper limit of reference value of
ALT for the illness) ÷ (maximum ALP/upper
limit of reference value of ALP for the same
period)] of 9.0 was lower than that of the ﬁve
typical episodes (12.8–27.2). Case 2’s second
episode was also different from the other typi-
cal episodes, with a lower R (7.1) and a rela-
tively rapid increase in bilirubin concentration
and hepatic failure. This episode more closely
resembled fulminant hepatitis rather than
typical acute hepatitis. 
One of the most common causes of acute
hepatic injury in Korea is viral hepatitis
(Chun et al. 2002). In our cases, viral markers
for HAV and HBV were all negative. HCV
markers were positive in two cases. Case 1 was
positive for anti-HCV, but viral RNA was
negative by PCR. This absence of active viral
RNA makes it unlikely that the acute hepatic
injury was caused by HCV. In contrast, case 4
Cheong et al.
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Table 1. Results of environmental monitoring in ﬁve locations and analysis of three bulk samples.
Air samples (by location) Bulk waste samples
EC DI ULP 1 ULP 2 ULP 3 B-ULP1 B-ULP2 A-ULP
MSD GC  GC  MSD GC  MSD MSD MSD GC  MSD MSD MSD 
Chemical (area %) (ppm) (ppm) (area %) (ppm) (area %) (area %) (ppm) (area %) (area %) (area %) (area %)
2-Butoxyethanol 4.20 1.5 17.88 1.5 17.88
MDA 0.63
4-Methyl-2-pentanone 11.79 1.77 10.00 6.17
Butyl acetate
Cyclohexanone 1.93 2.05 1.66 2.09 3.59 2.09
DMAc 2.17 0.87 0.86 0.25 3.52 1.52 0.25 3.52
DMF 1.75 2.35 1.04 1.75 2.35
1-Butanol 1.01 1.01
Pyridine 3.60 1.77 1.93 26.07 2.08 1.65 26.07 2.08
Tetrahydrofurane 6.00 6.85 7.49 2.65 3.73 6.11 2.65 3.73
Toluene 0.015 0.041 8.996 — 9.127 1.39 —
Xylene 0.026 7.646 8.052
Trimethylbenzene 5.44
1,4-Butanediol 4.58 5.48 30.33 28.37 30.33
Pentadecane 1.71 2.54
Tetradecane 1.05
Total identiﬁed (%) 33.27 20.43 32.67 67.61 30.57 49.84 67.61 30.57
Abbreviations: DI, dry evaporative incinerator; EC, evaporative concentrator; GC, gas chromatography; MSD, mass selective detector; ULP, simulated unslaked lime process. was positive in HCV-PCR but was negative
for anti-HCV. Therefore, it is possible that
HCV contributed to the development of
acute hepatitis in this case. The prolonged
course of case 4, compared with the other
cases (15 weeks vs. 4–8 weeks), and the mild
cirrhotic changes on pathology suggest the
possibility of a mixed etiology for the illness
of case 4.
When we applied the criteria for the diag-
nosis of drug-induced hepatic injury, our cases
were compatible with toxic (or drug-induced)
hepatic injury (Benichou 1990; Danan and
Benichou 1993; Maria and Victorino 1997).
Severe destruction of liver cells with bridg-
ing necrosis was noted in all cases. However,
in severe cases (cases 3 and 4), a wide area of
necrosis was observed; this may indicate a
change to subacute necrosis, which represents
the possibility of transformation into chronic
hepatitis. Actually, one case (case 4) already
exhibited early cirrhotic change on pathology.
The role of herbal medication and hepato-
toxic drugs in the development of acute
hepatic injuries in two of the cases is of inter-
est. Case 2 took herbal medications for 2 weeks
and case 3 took only two doses. The label of
the herbal medication indicated 28 compo-
nents, at least one of which can be hepatotoxic
(genistein, a phytoestrogen) (Hwang et al.
2001). However, the main reason case 2 took
the herbal medication was for severe fatigue,
which is related to the development of toxic
hepatitis. In a case report of toxic hepatitis
caused by this herb component, Hwang et al.
(2001) described a cholestatic hepatitis that
developed after the ingestion of a daily dose
10-fold higher than that of our case 4 for a
period of 7 weeks. However, the strong simi-
larity of the pattern of increase in the liver
enzyme concentration and the R value, the
similar clinical course of cases 2 and 3, and the
short-term use of the herbal medication
strongly suggests that the herbal medication
was not a signiﬁcant factor in the development
of toxic hepatitis in these two cases.
Furthermore, contrary to cases 2 and 3,
most reported cases of hepatitis related to
herbal medications have been cholestatic
hepatitis (Breen et al. 1986; Chitturi and
Farrell 2000; Hwang et al. 2001; Langmead
and Rampton 2001; Larrey and Pageaux
1995). These authors elucidated that the role
of the herbal medication could be minor or, at
best, an aggravating agent, rather than being a
causative agent. In the case of case 3, she had
only two doses of the herbal medication after
her clinical manifestation had begun. 
The NSAIDs taken by case 2 are also a
potential candidate as the cause of his hepatitis.
He received one ampule of 100 mg tolperisone
HCl (a muscle relaxant) and diclofenac-β-
dimethylaminoethanol (diclofenac) 90 mg/day
for 8 days. Tolperisone has been reported to be
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Table 2. Clinical characteristics of the toxic hepatitis cases.
Characteristic Case 1 Case 2 Case 3 Case 4 Case 5
Age/sex 51 years/male 35 years/male 41 years/female 53 years/female 26 years/male
Department Selection Evaporator Maintenance (welding) Selection Dry distillation incinerator
Job title Sorting and treating waste liquids Controlling evaporator Welding and cleaning Sorting waste Controlling incinerator
Employment dates 20 December 1986–10 January 2001 18 April 1994 1 May 1993 1 October 2000 25 February 2001
Onset April 2001 Late June 2001 Early July 2001 Early August 2001 Middle of 2001
Date of admission 1 May 2001 12 July 2001 30 July 2001 24 August 2001 19 September 2001
Duration of illness (weeks)a 2 (4)b 7 (9) 8 (10) 15 7
Viral hepatitis markers HAV, HBV marker (–) HAV, HBV marker (–) HAV, HBV marker (–) HAV, HBV marker (–) HAV, HBV marker (–)
anti-HCV (+) anti-HCV (–) anti-HCV (–) anti-HCV (–) anti-HCV (–)
HCV PCR (–) HCV PCR (+)
Biopsy Hepatitic damage  No biopsy Hepatitic damage Hepatitic damage Hepatitic damage
Bridging necrosis Bridging necrosis Bridging necrosis Bridging necrosis
Wide periportal necrosis Fatty degeneration Cirrhotic nodule
Cholestasis
Rc 9.0/12.8b  27.2/7.1b 23.1 24.5 19.7
Comments Took herbal medication Took herbal medication
and NSAIDs
Patient died
Abbreviations: +, positive; –, negative.
aTime period between admission and the remission of the AST and ALT. b1st illness (2nd illness). c(Maximum ALT/upper limit of reference value of ALT for the illness) ÷ (maximum
ALP/upper limit of reference value of ALP for the same period).
A B
C D
Figure 1. Process of unslaked lime solidiﬁcation reaction. (A) Reaction is performed in a warehouse with
the windows removed. (B) For each reaction, 100–250 drums of liquid wastes and 7–12 tons of unslaked
lime are loaded in a constant ratio with liquid wastes. (C) As the wastes and unslaked lime are mixed, thick
noxious vapors rise during the heat reaction and escape through the open windows; the full reaction takes
> 12 hr with emission of huge amounts of noxious gases and vapors. (D) Final stage of the process after
10 hr of thermochemical reaction.hepatotoxic in animals but not in humans. In
this case, the dosage given was much smaller
than the reported toxic dosage. However, we
could not completely exclude the possibility
that it might have exaggerated his hepatitis
during his second return to work. 
Diclofenac has been reported to be a
hepatotoxic compound (Bhogaraju et al.
1999; Breen et al. 1986; Helfgott et al. 1990;
Iveson et al. 1990; Ouellette et al. 1991;
Purcell et al. 1991; Ramakrishna and
Viswanath 1994; Scully et al. 1993). From an
evaluation of 180 cases of diclofenac hepato-
toxicity, Banks et al. (1995) reported that the
hepatotoxicity was usually asymptomatic,
with a few mild symptoms. About 1–5 cases
of diclofenac hepatotoxicity developed per
100,000 prescriptions, with the average latency
of 3–12 weeks.
Epidemiologic evaluation. Forty-eight
workers (36 blue-collar workers and 12 ofﬁce
workers or drivers) have been working in this
plant since 2001, and 6 workers, including
two cases, retired after this outbreak of hepati-
tis. We evaluated liver function tests, ultra-
sonography, and immunologic markers of
viral hepatitis in all employees except the three
cases admitted to the hospital and three other
absences. Two of them had mildly increased
liver enzymes, and both had a previous history
of abnormal liver function tests. One was sus-
pected of having alcoholic liver disease and the
other suffered from fatty liver due to being
overweight. Based on ultrasonography, we sus-
pected that 6 workers had fatty liver, which is
one of the most common liver disorders
among Korean workers (Cheong and Kim
1997). Another worker was suspected of hav-
ing chronic hepatitis on the basis of ultra-
sonography. but did not have an abnormal
liver function test. Of the 6 retired workers,
2 had chronic liver disease. A review of med-
ical records showed that both had elevated
liver enzyme levels from early 2001, both had
positive HBV markers, and one was diagnosed
with liver cirrhosis related to HBV and alco-
holic liver disease. Therefore, they were not
included in the cases. The incidence of toxic
hepatitis was 10.4% in all of the workers and
13.9% in the production workers. 
All of the cases developed within a
4-month period, from May to September
2001. Four of them occurred in a 2-month
period, between mid-July and mid-September
2001. Even the recurrent cases of hepatitis
occurred in this period. This phenomenon of
heavy clustering over a narrow time span
strongly suggests a possible association with
exposure to toxic agents. The duration of ill-
ness in these cases was 4–15 weeks (median,
7 weeks). 
All cases were production workers who
had either participated in the unslaked lime
process or worked nearby. In contrast, none
of the workers who worked far from the
unslaked lime process (e.g., laboratory, ofﬁce,
and waste water treatment staff) had hepatitis
(Figure 4). 
Inference on the etiology. We suspect that
the unslaked lime process is responsible for
the development of this toxic hepatitis out-
break for the following reasons: a) during the
2 years before the outbreak, there were no sig-
niﬁcant changes in the amount and composi-
tion of the wastes or in the origin of the raw
waste materials, except for the introduction of
this unslaked lime process; b) no cases of
hepatitis occurred before the introduction of
the unslaked lime process; and c) simulation of
the unslaked lime process showed that several
Cheong et al.
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Figure 3. Pathologic findings of toxic hepatitis cases. (A) PAS-stained liver from case 5 showing spotty
necrosis of hepatocytes and clumped Kupffer cells containing PAS-positive material (arrows); these ﬁnd-
ings are compatible with the remission stage of acute hepatitis and with toxic hepatitis (magnification,
400×). (B) Hematoxylin and eosin (H&E)–stained liver from case 1 showing portal tracts that are slightly
enlarged and infiltrated with inflammatory cells (magnification, 400×). (C) H&E-stained liver from case 5
showing central to portal bridging necrosis (magniﬁcation, 200×). (D) Masson trichrome staining of liver
from case 4 showing wide periportal necrosis extending into the portal-to-portal area, with regenerative
nodules present (magniﬁcation, 100×).
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Figure 2. Clinical course for each case shown by AST level. Seven episodes of acute hepatic injury
occurred in ﬁve workers from the plant. Case 1’s ﬁrst episode occurred in May 2001, but the episode was
limited only to laboratory ﬁndings. Most of the clinical episodes of acute hepatic injury occurred between
July and September 2001. The second episodes of cases 1 and 2 developed after they returned to work.hepatotoxic materials are generated in the
waste and vapors. Investigations on the other
possible sources, including drinking water,
food supply, and specific process in each
warehouse, did not suggest any other
causative factors. The phenomenon of the
highly time- and place-dependent clustering
of the cases can be explained by the predomi-
nant wind direction. Annual climate data
shows that the wind direction in July was
from the southwest toward the northeast, the
direction from the vapor source toward the
victims; this explains the clustering of the
cases between July and September.
Considering the clinical, epidemiologic,
and pathologic characteristics, the derivable
clues for causative agents of this outbreak are as
follows: a) the main exposure occurred between
June and August 2001; b) the agent should
cause acute necrosis of liver parenchyma; c)a n
endogenous toxin is more relevant than an
idiosyncratic reaction for the hepatotoxicity in
these cases, given the relatively high incidence,
although there is still a possibility of idio-
syncrasy in view of the fact that cases 1 and 2
had eosinophilia and experienced a more
severe, even fatal, relapse after reexposure;
d) the zonal type of necrosis of hepatocytes
was present, mainly zone I (periportal), but
zone III (central vein) was also present in
some of the cases; e) steatosis and cholestasis
were only occasionally observed; f ) the expo-
sure route was suspected to be respiratory
inhalation (neither oral intake nor skin
absorption is plausible, considering the work
processes and the raw material treated); g) the
agent is probably a highly potent hepatotoxin
with sufﬁciently high vapor pressure and toxic
potency, which by inhalation, can cause toxic
hepatitis in workers at least 100 m away from
the source; h) the toxic activity of the agent
should be specific to the liver without seri-
ously affecting other organs or systemic effect;
and i) the agent appears to have a relatively
long latency (> 2 weeks), and repetitive or
chronic exposure could also accelerate the
toxic reaction.
Taking into account these inferences, we
tried to match the clinical, pathologic, and toxi-
cologic clues to the well-known hepatotoxic
chemicals and those chemicals found in the
samples from this industrial waste plant, such
as DMF, DMAc, pyridine, and methylene-
dianiline (MDA) (Bastian 1984; Hall 1992;
Kopelman 1966; McGill and Motto 1974;
Tillmann et al. 1997; Williams et al. 1974).
For each toxicant, we listed the toxic properties
and its clinical characteristics, but none of
them completely matched the criteria for the
potential causative agent in the current cases. 
DMAc and DMF, both solvents that can
potentially cause acute toxic hepatitis (Baum
and Suruda 1997; Choi et al. 2001; Kang
et al. 1991; Kim et al. 1991; Marino et al.
1994; Spies et al. 1995), were detected in the
environmental samples; such common sol-
vents, which are used by many of the client
industries of this plant, are likely to be the
causative agents of this outbreak. Carbon
tetrachloride is one of the strongest chemicals
that can induce toxic hepatitis while showing
hepatocellular necrosis with fatty change, but
the clinical and pathologic characteristics we
found do not correspond exactly with this
agent, and it was not detected in our environ-
mental samples. Pyridine, a hepatotoxin with
its own peculiar odor, was also detected in the
raw material samples (Baxter 1947; Carlson
1996; International Labor Office 1983;
Pollock et al. 1943). Most of the hepatitis
cases said that the vapor from the process was
highly irritating; therefore, pyridine in the
waste treated is a strong candidate. However,
the environmental sampling was focused on
the qualitative detection of the compound.
Because the simulation of unslaked lime was
performed on a much smaller scale than the
true case and because the simulation was
undertaken in November, the chemical com-
position may have varied significantly from
that of June or August. 
Another possibility is that the various
chemicals detected in the analysis underwent
an interaction among themselves, which syn-
ergistically raised their toxicity compared with
the original material. Our cases showed rela-
tively longer latency than usual toxic hepatitis;
however, following the usual course of toxic
hepatitis, there were no systemic symptoms or
signs. Complex wastes have been evaluated for
their toxicity (Meyer 1983; Simmons et al.
1988, 1994). It has been reported that the
lowest dose of toxicity in a complex of several
chemicals can be lower than that of any single
chemical component, and latency can be
longer (Dossing and Ranek 1984; Hodgson
et al. 1989; Kimbroug 1983; Landrigan 1983;
Neal 1983; Thilly et al. 1983). Simmons
et al. (1988) suspected that toxic hepatitis
could be caused by the synergistic interaction
of various unknown chemicals generated dur-
ing the unslaked lime process through thermo-
chemical reactions.
In cases 2 and 3, herbal medicine and
NSAIDs should be considered an aggravating
factor—by synergistic or additive effect—on
the liver damaged by hepatotoxic chemicals.
However, we do not think they are the initia-
tors. Cases 2 and 3 took the herbal medicine
only after the severe fatigue had begun. Case 3
had only one dose of the herbal medicine after
the symptom began. NSAIDs were given to
case 2 after the recovery from the acute
hepatitic episode. Intravenous injection of
NSAIDs, together with resumed exposure
could have triggered fulminant hepatitis. 
Conclusion 
We conclude that this outbreak of toxic
hepatitis developed as a result of exposure to
the hepatotoxic materials generated during the
treatment of industrial waste using unslaked
lime. Between May and September 2001, ﬁve
hepatitis cases occurred, including one death,
due to fulminant hepatitis. The pathologic
and epidemiologic ﬁndings clearly suggest that
these cases of acute hepatitis were toxic hepati-
tis caused by occupational exposure rather
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Figure 4. Diagram of the industrial waste plant showing the work areas of the hepatitis cases. Case 1
worked in unslaked lime processing. Workplaces of the other cases were northeast from the unslaked
lime process warehouse. In this area, the seasonal wind from the southwest is limited to July.than viral infection or medication, such as
herbal medicine and NSAIDs. In environ-
mental samples, we detected several hepato-
toxic chemicals, including pyridine, DMF,
DMAc, and MDA, in addition to solvents
such as toluene, styrene, and xylene. Although
we could not conﬁrm the exact causative agent
among them, the latency of the illness and
other clinical characteristics strongly suggests
that one of the chemicals, or the synergistic
effect of the interaction among the complex
components, evoked the hepatitis.
In general, the processes of treating
industrial waste are conducted in confined
areas. However, this plant had invented a
new adaptation to improve the original
unslaked lime process by introducing a ther-
mochemical reaction. Waste oil or solvents
are composed of many chemicals, with not
only signiﬁcant hepatotoxicity but also other
organ toxicity. Therefore, these processes in
the waste-treatment industry must be super-
vised and regulated under the direction of the
public environmental protection authorities.
Any arbitrary modiﬁcation of such processes
should be prohibited until the safety has been
evaluated for any potential hazards to the
environment and the workers.
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